Granuloma Annulare
Dermal papules coallescing into linear lesions on the dorsal hand of a 10-year-old boy.

GRANULOMA ANNULARE

Granuloma Annulare (GA) is a benign, inflammatory, delayed hypersensitivity reaction in the skin to an as of yet unidentified antigen.

Clinical

The common and localized form of GA usually presents as red, dermal papule forms and spreads outward involuting centrally. Later, multiple dermal papules linked together form spreading, annular rings. Localized GA is most common on the dorsa of the hands but lesions may occur elsewhere, e.g. the elbows, fingers, palms, dorsa of the feet, etc.

Nodular GA

Nodular or subcutaneous GA presents as painless, firm subcutaneous nodules and occurs almost exclusively in children, usually on the legs.

Papular, Umbilicated and Perforating GA

Papular, umbilicated GA presents as umbilicated papules with a keratotic core. In the past, perforation was thought to occur, but this is rarely true.

Chronic, Disseminated Form

A chronic, disseminated or generalized form may occur. It represents about 10% of overall cases of GA and is much more common in adults. Its response to therapy is poor and usually does not spontaneously remit. The morphology may be annular or papular. Rarely, this subtype is associated with hematologic malignancy.

Acute, Disseminate GA

GA, when thought of as a histologic pattern, may represent a variety of entities or disease processes. An acute and more widespread form may occur as an allergic reaction to a new medication. Drug-induced GA has been associate with a variety of medications including pegylated IFN-alpha, hepatitis B vaccination, infliximab, diclofenac, allopurinol and amlodipine. The time delay between start of the medication and presentation of the GA may be weeks to months.

Acute Palmoplantar GA

A rare palmoplantar form occurs (see image below) and may present acutely. The diagnosis of palmar GA can be difficult owing to its atypical presentation. In a clinicopathological study of seven patients with biopsy proven GA exclusively on the palms, the diagnosis was not suspected clinically in five cases [Granuloma annulare on the palms: a clinicopathological study of seven cases. Ind J Dermatol, Venereol, 2012;78:468-74.

Other Variants

Annular Elastolytic Giant Cell Granuloma is considered by some a variant of GA as is Actinic Granuloma (photodistributed GA).

Differential Diagnosis

Although annular, there is no scale as seen in tinea_corporis. Any dermal infiltrative process might be considered (e.g. sarcoidosis).

Treatment, Brief Overview

Steroids, IL and Topical

If few in number, triamcinolone 5 mg/cc may be injected into the border. Usually one injection is sufficient for any single lesion. If many lesions are present, and IL steroid is impractical or not desired, a potent topical steroid may be tried.

Antimalarials

Antimalarials have been used in the past, usually starting with hydroxychloroquine. In one review, all 6 patients treated with chloroquine improved, 5 of whom had failed previous treatment with hydroxychloroquine.

UVB

Narrow band UVB, and PUVA (both standard and bath have been reported useful. Phototherapy (5/week) with UVA-1 (340-400 nm) alone has been shown effective. However, phototherapy should be avoided in GA occuring in sun-exposed areas (e.g. actinic granuloma).

Ruxolitinib

Ruxolitinib 1.5% cream BID can be very effective for localized lesions. In one case report [JAAD Case Reports Aug 2024], BID use resulted in complete resolution of lesions in 12 weeks without any adverse events.

Tofacitinib

Oral tofacitinib for diffuse lesions has been used with dramatic success.

Other Therapies

Any sort of trauma may improve GA. All of the following have been reported to improve GA: intralesional saline, biopsy, incision of lesions, scarification (i.e., the use of a 19-gauge needle drawn across the lesion until capillary bleeding occurs), repetitive pricking and cryotherapy.

Apremilast has been reported anecdotally effective in 4 patients [JAMA Derm 2019;155;1318]. All patients responded with in 6-8 weeks. All did well on a maintenance therapy of 30 mg/day.

Tumor necrosis factor (TNF)-α inhibitors have been reported to improve GA. Adalimumab seems to be the most promising with anecdotal reports of rapid clinical response, generally within 2 to 6 weeks, with sustained remission after therapy discontinuation [JAAD 2016;74;127]. Caution must be exercised here as biologic agents have been reported to trigger GA.

Additional Pictures

Granuloma Annulare


Granuloma Annulare

Granuloma Annulare


Granuloma Annulare
A rare palmoplantar GA occurs and may present acutely.


Granuloma Annulare
Disseminated GA in an adult. While GA is generally a benign condition, in older adults, especially with atypical or widespread presentations, it can sometimes be associated with underlying malignancies, particularly hematologic ones, e.g. lymphoma, leukemia.


Granuloma Annulare

RegionalDerm

Who is Dr. White? | Privacy Policy | FAQs | Use of Images | Contact Dr. White


It is not the intention of RegionalDerm.com to provide specific medical advice, diagnosis or treatment. RegionalDerm.com only intends to provide users with information regarding various medical conditions for educational purposes and will not provide specific medical advice. Information on RegionalDerm.com is not intended as a substitute for seeking medical treatment and you should always seek the advice of a qualified healthcare provider for diagnosis and for answers to your individual questions. Information contained on RegionalDerm.com should never cause you to disregard professional medical advice or delay seeking treatment. If you live in the United States and believe you are having a medical emergency call 911 immediately.